These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 856605)

  • 21. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE; Hager WD; Perrier D; Powell JR; Graves PE; Michael UF
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting drug binding in plasma of elderly patients.
    Wallace S; Whiting B
    Br J Clin Pharmacol; 1976 Apr; 3(2):327-30. PubMed ID: 973967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.
    Lesko LJ; Narang PK; Yeager L; Cutler NR
    Eur J Clin Pharmacol; 1985; 28(3):339-45. PubMed ID: 4007039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood and saliva salicylate measurement in the monitoring of salicylate therapy.
    Pérez-Mateo M; Erill S; Cabezas R
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

  • 28. Binding of drugs by albumin and plasma protein.
    Vallner JJ
    J Pharm Sci; 1977 Apr; 66(4):447-65. PubMed ID: 323460
    [No Abstract]   [Full Text] [Related]  

  • 29. Digoxin-quinidine interaction in patients with renal failure.
    Hirschberg R; Schaefer K; von Herrath D; Kreutz G; Kewitz H
    Klin Wochenschr; 1981 May; 59(10):521-2. PubMed ID: 7241953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.
    Roberts MS; Rumble RH; Wanwimolruk S; Thomas D; Brooks PM
    Eur J Clin Pharmacol; 1983; 25(2):253-61. PubMed ID: 6628510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin injection on plasma protein binding of bilirubin and salicylate in rats.
    Wiegand UW; Levy G
    J Pharm Sci; 1979 Dec; 68(12):1483-6. PubMed ID: 529035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    Biochem Pharmacol; 1982 Nov; 31(21):3483-7. PubMed ID: 7150368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.
    Grafnetterová J; Vodrázka Z; Jandová D; Schück O; Tomásek R; Lachmanová J
    Clin Nephrol; 1976 Oct; 6(4):448-50. PubMed ID: 975643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
    Chien YW; Lambert HJ; Karim A
    J Pharm Sci; 1974 Dec; 63(12):1877-9. PubMed ID: 4449018
    [No Abstract]   [Full Text] [Related]  

  • 37. Decreased protein binding of salicylates in Kawasaki disease.
    Koren G; Silverman E; Sundel R; Edney P; Newburger JW; Klein J; Robieux I; Laxer R; Giesbrecht E; Burns JC
    J Pediatr; 1991 Mar; 118(3):456-9. PubMed ID: 1999792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma protein binding of etomidate in patients with renal failure or hepatic cirrhosis.
    Carlos R; Calvo R; Erill S
    Clin Pharmacokinet; 1979; 4(2):144-8. PubMed ID: 455872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine].
    Camsonne R; Moulin MA; Ryckelynck JP; Mignot P; Albessard F; Perault M; Bigot MC; Richard O
    Nouv Presse Med; 1982 Oct; 11(41):3062-3. PubMed ID: 7145692
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.
    Sweeney KR; Chapron DJ; Brandt JL; Gomolin IH; Feig PU; Kramer PA
    Clin Pharmacol Ther; 1986 Nov; 40(5):518-24. PubMed ID: 3769383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.